Supplements
Development and Future of Automated Insulin Delivery (AID) Systems
A special 13-article supplement brought to you from Medtronic examines the “Development and Future of Automated Insulin Delivery (AID) Systems.
READ MORESponsored by: Medtronic
Highlights from the 2023 Supplement to Diabetes Technology & Therapeutics on Continuous Glucose Monitoring
Discover infographics and video summaries of select articles from the Diabetes Technology & Therapeutics Supplement on Continuous Glucose Monitoring, published in 2023.
READ MORESponsored by: Abbott Diabetes Care
Continuous Glucose Monitoring
As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there is a growing body of evidence supporting the use of this technology in improving diabetes outcomes for patients with Type 1 or Type 2 Diabetes. A new supplement in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) provides an excellent perspective of the past, present, and future of CGM.
This supplement was produced through an unrestricted educational grant from Abbott’s diabetes care business.
READ MORESponsored by: Abbott
ATTD 2023 Abstracts
The Official Journal of ATTD Advanced Technologies & Treatments for Diabetes Conference 22-25 February 2023 I Berlin & Online
READ MORESociety Affiliations
The Official Journal of: